Testing effectiveness (Phase 2)Study completedNCT00546793
What this trial is testing
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Who this might be right for
NHLLymphoma, Non-HodgkinLymphoma, B-Cell+15 more
Gilead Sciences 32